Aspirin Resistance Reversibility in Diabetic Patients — ARRDM

Aspirin Resistance Clinical Trial

Official title:
Impact of Different Pharmacological Formulations on Aspirin Resistance Reversibility in Diabetics Patients

Status Unknown status

Clinical Trial Summary

The aim of the study is assessing the prevalence of aspirin resistance in a cohort of diabetic patients. Those found resistant has been undergone pharmacological tests using different drug formulations to investigate the reversibility of aspirin resistance.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Aspirin Resistance

Clinical Trial Details

NCT number	NCT01935193
Study type	Interventional
Source	Azienda Ospedaliera San Giovanni Battista
Contact	Marta Bisi, MD
Phone	+393476985414
Email	martadoro@hotmail.com
Status	Unknown status
Phase	Phase 4
Start date	November 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01432652` - The Efficacy of Aspirin in the Postoperative Period in Vascular Surgery	N/A
Completed	`NCT00948987` - Mechanism Based Resistance to Aspirin	Phase 1
Not yet recruiting	`NCT01547039` - Platelet Reactivity and MES During CEA	N/A
Completed	`NCT01159639` - Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting	Phase 4
Completed	`NCT00792272` - Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients	N/A
Completed	`NCT00466154` - The Effect of Serum LDL Lowering on Aspirin Resistance	N/A
Completed	`NCT01104441` - Aspirin Resistance and Prognosis of Patients With Critical Limb Ischaemia